GGrantIndex
← Search

PURPOSE: TO EXERCISE OPTION PERIOD 1 AND FUND 31 ADDITIONAL CASES FOR PAYMENTS 1-3 IN THE AMOUNT $52,700.00 (31 CASES X $2,000 PER CASE X 85%).

$265,200N02FY2019CANIH

Internat'L Institute/Molecular Oncology, Poznan

Investigators

Abstract

The contractor collected biospecimens included tumor tissue, normal tissue, and blood according to an NCI-provided protocol. The biospecimens were used for proteogenomic characterization studies. The contractor collected corresponding clinical data including medical history, demographic information, diagnostic data, and annual follow-up reports.

View original record on NIH RePORTER →
PURPOSE: TO EXERCISE OPTION PERIOD 1 AND FUND 31 ADDITIONAL CASES FOR PAYMENTS 1-3 IN THE AMOUNT $52,700.00 (31 CASES X $2,000 PER CASE X 85%). · GrantIndex